These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
349 related articles for article (PubMed ID: 23416985)
1. Evolution and dynamics of pancreatic cancer progression. Yachida S; Iacobuzio-Donahue CA Oncogene; 2013 Nov; 32(45):5253-60. PubMed ID: 23416985 [TBL] [Abstract][Full Text] [Related]
2. Translational research in pancreatic cancer: KRAS and beyond. Boeck S; Ormanns S; Haas M; Bächmann S; Laubender RP; Siveke JT; Jung A; Kirchner T; Heinemann V Pancreas; 2014 Jan; 43(1):150-2. PubMed ID: 24326376 [No Abstract] [Full Text] [Related]
3. Genetic alterations of K-ras, p53, c-erbB-2, and DPC4 in pancreatic ductal adenocarcinoma and their correlation with patient survival. Shin SH; Kim SC; Hong SM; Kim YH; Song KB; Park KM; Lee YJ Pancreas; 2013 Mar; 42(2):216-22. PubMed ID: 23344532 [TBL] [Abstract][Full Text] [Related]
4. Disruption of p16 and activation of Kras in pancreas increase ductal adenocarcinoma formation and metastasis in vivo. Qiu W; Sahin F; Iacobuzio-Donahue CA; Garcia-Carracedo D; Wang WM; Kuo CY; Chen D; Arking DE; Lowy AM; Hruban RH; Remotti HE; Su GH Oncotarget; 2011 Nov; 2(11):862-73. PubMed ID: 22113502 [TBL] [Abstract][Full Text] [Related]
5. Clinical Effect of Driver Mutations of Gu Y; Ji Y; Jiang H; Qiu G Genet Test Mol Biomarkers; 2020 Dec; 24(12):777-788. PubMed ID: 33347393 [No Abstract] [Full Text] [Related]
6. Genetics and Biology of Pancreatic Ductal Adenocarcinoma. Dunne RF; Hezel AF Hematol Oncol Clin North Am; 2015 Aug; 29(4):595-608. PubMed ID: 26226899 [TBL] [Abstract][Full Text] [Related]
7. Clinical significance of the genetic landscape of pancreatic cancer and implications for identification of potential long-term survivors. Yachida S; White CM; Naito Y; Zhong Y; Brosnan JA; Macgregor-Das AM; Morgan RA; Saunders T; Laheru DA; Herman JM; Hruban RH; Klein AP; Jones S; Velculescu V; Wolfgang CL; Iacobuzio-Donahue CA Clin Cancer Res; 2012 Nov; 18(22):6339-47. PubMed ID: 22991414 [TBL] [Abstract][Full Text] [Related]
8. Adenosquamous carcinoma of the pancreas harbors KRAS2, DPC4 and TP53 molecular alterations similar to pancreatic ductal adenocarcinoma. Brody JR; Costantino CL; Potoczek M; Cozzitorto J; McCue P; Yeo CJ; Hruban RH; Witkiewicz AK Mod Pathol; 2009 May; 22(5):651-9. PubMed ID: 19270646 [TBL] [Abstract][Full Text] [Related]
9. Genetic and epigenetic alterations of familial pancreatic cancers. Brune K; Hong SM; Li A; Yachida S; Abe T; Griffith M; Yang D; Omura N; Eshleman J; Canto M; Schulick R; Klein AP; Hruban RH; Iacobuzio-Donohue C; Goggins M Cancer Epidemiol Biomarkers Prev; 2008 Dec; 17(12):3536-42. PubMed ID: 19064568 [TBL] [Abstract][Full Text] [Related]
10. Immortalizing the complexity of cancer metastasis: genetic features of lethal metastatic pancreatic cancer obtained from rapid autopsy. Embuscado EE; Laheru D; Ricci F; Yun KJ; de Boom Witzel S; Seigel A; Flickinger K; Hidalgo M; Bova GS; Iacobuzio-Donahue CA Cancer Biol Ther; 2005 May; 4(5):548-54. PubMed ID: 15846069 [TBL] [Abstract][Full Text] [Related]
11. The Roles of Frequently Mutated Genes of Pancreatic Cancer in Regulation of Tumor Microenvironment. Sun H; Zhang B; Li H Technol Cancer Res Treat; 2020; 19():1533033820920969. PubMed ID: 32372692 [TBL] [Abstract][Full Text] [Related]
12. Variant Profiling of Candidate Genes in Pancreatic Ductal Adenocarcinoma. Huang J; Löhr JM; Nilsson M; Segersvärd R; Matsson H; Verbeke C; Heuchel R; Kere J; Iafrate AJ; Zheng Z; Ye W Clin Chem; 2015 Nov; 61(11):1408-16. PubMed ID: 26378065 [TBL] [Abstract][Full Text] [Related]
18. Different subtypes of intraductal papillary mucinous neoplasm in the pancreas have distinct pathways to pancreatic cancer progression. Mohri D; Asaoka Y; Ijichi H; Miyabayashi K; Kudo Y; Seto M; Ohta M; Tada M; Tanaka Y; Ikenoue T; Tateishi K; Isayama H; Kanai F; Fukushima N; Tada M; Kawabe T; Omata M; Koike K J Gastroenterol; 2012 Feb; 47(2):203-13. PubMed ID: 22041919 [TBL] [Abstract][Full Text] [Related]
19. Immunohistochemically detected expression of 3 major genes (CDKN2A/p16, TP53, and SMAD4/DPC4) strongly predicts survival in patients with resectable pancreatic cancer. Oshima M; Okano K; Muraki S; Haba R; Maeba T; Suzuki Y; Yachida S Ann Surg; 2013 Aug; 258(2):336-46. PubMed ID: 23470568 [TBL] [Abstract][Full Text] [Related]
20. A human cancer xenograft model utilizing normal pancreatic duct epithelial cells conditionally transformed with defined oncogenes. Inagawa Y; Yamada K; Yugawa T; Ohno S; Hiraoka N; Esaki M; Shibata T; Aoki K; Saya H; Kiyono T Carcinogenesis; 2014 Aug; 35(8):1840-6. PubMed ID: 24858378 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]